COMPASS Pathways股价盘前大涨8.6%,抑郁症疗法后期试验数据积极

美股速递
Jul 07

在公布其抑郁症治疗药物的积极后期试验数据后,COMPASS Pathways plc的股价在盘前交易时段飙升了8.6%。这一显著涨幅反映了市场对该药物研发进展的乐观情绪,以及其未来商业潜力的认可。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10